Chen, Chi-JenChi-JenChenPau-Chung CHENLin, Meng-HungMeng-HungLinLee, Chuan-PinChuan-PinLeeHsieh, Wu-ShiunWu-ShiunHsiehPau-Chung CHENChen, Pau-ChungPau-ChungPau-Chung CHENChenHSIAO-YU YANGDoyle, PatPatDoyleHo, Wen-ChaoWen-ChaoHoPAU-CHUNG CHEN2020-05-142020-05-1420191055-9965https://scholars.lib.ntu.edu.tw/handle/123456789/492940We investigated the association between taking herbal medicine (HM) containing aristolochic acid (AA) and the risk of primary liver cancer (PLC) among patients with hepatitis C virus (HCV) infection.en[SDGs]SDG3acetylsalicylic acid; aristolochic acid; atorvastatin; benazepril; captopril; cilazapril; enalapril; fluindostatin; fosinopril; interferon; lisinopril; metformin; mevinolin; perindopril; pravastatin; quinapril; ramipril; ribavirin; rosuvastatin; simvastatin; aristolochic acid; aristolochic acid I; carcinogen; adult; aged; Article; cancer risk; Chinese medicine; clinical evaluation; cohort analysis; disease association; female; follow up; hepatitis C; herbal medicine; human; incidence; liver cancer; major clinical study; male; middle aged; national health insurance; population research; prescription; priority journal; prospective study; chemistry; complication; Hepacivirus; hepatitis C; herbal medicine; liver tumor; pathogenicity; procedures; risk factor; Aristolochic Acids; Carcinogens; Female; Hepacivirus; Hepatitis C; Herbal Medicine; Humans; Liver Neoplasms; Male; Prospective Studies; Risk Factorsjournal article10.1158/1055-9965.EPI-19-0023314096112-s2.0-85074379059WOS:000498663900014https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074379059&doi=10.1158%2f1055-9965.EPI-19-0023&partnerID=40&md5=7da0d4e174862c75f7f0b621459ccbb7